Search results
UK pharma group reprimands Novo Nordisk for undisclosed payments
Pharmaceutical Technology· 5 days agoGlobalData is the parent company of Pharmaceutical Technology. Pfizer’s transgression was promoting...
Crossject secures funding from French Government for needle-free platform
Pharmaceutical Technology· 24 hours agoIn November 2023, US-based Micron Biomedical received $23.6m in funding from the Bill & Melinda...
Axita Cotton Ltd Management Discussions | India Infoline
India Infoline· 3 days agoAxita Cotton Ltd Management Discussions: Check out the latest updates, and news about the Axita Cotton management discussions at India Infoline
Old Delhi’s Bakrid goats are living king-size in UP. Morning gargle, sprinklers, big meals
Theprint· 7 days ago“It’s time for their lunch,” announced Iqbal, as the men filled the iron taslas (deep bowls) with...
Crossject secures funding from French Government for needle-free platform
Medical Device Network· 24 hours agoIn November 2023, US-based Micron Biomedical received $23.6m in funding from the Bill & Melinda...
Indian drugmakers seek govt tax reliefs, incentives to spur innovation - ETPharma
The Economic Times· 7 days agoHyderabad: India's pharmaceutical companies are hoping for tax incentives and financial assistance...
Pune's Zika Count Reaches 18; 10 Are Pregnant Women - Here's Area-Wise Breakdown
Free Press Journal· 2 days agoDr Sanjay Patil, Chairman of the Indian Medical Association (IMA), Pune Chapter, advised individuals...
BARDA selects Allucent for D-COHRe initiative in US
Clinical Trials Arena· 3 days agoIn May 2024, Allucent secured a $25.5m Biomedical Advanced...Research and Development Authority (BARDA)-funded grant to support a decentralised Covid-19 ...
Monsoon Diseases: Expert Shares Tips To Keep Typhoid At Bay
Times Now· 6 days agoWith the onset of monsoon season, concerns rise over the spread of typhoid fever in India. As rains...
Supreme Petrochem Ltd Management Discussions | India Infoline
India Infoline· 6 days agoThe global economy experienced another year of slow growth in F.Y. 2023-24 marked by high inflation, high interest rates, rising geopolitical tensions, weak global trade growth ...